Nebula Genomics

ProPhase Diagnostics

ProPhase Labs, Inc. is a growth oriented and diversified diagnostics, genomics and biotech company that seeks to leverage its CLIA lab services to provide whole genome sequencing and research direct to consumers and build a genomics database to be used for further research. The Company continues to provide traditional CLIA molecular laboratory services, including COVID-19 testing. The Company also continues to operate a state-of-the-art contract manufacturing subsidiary and the TK Supplements line of dietary supplements, distributed in food, drug and mass stores throughout the country.

Dutchess Opportunity Fund

ProPhase Labs

Illumina, Inc. is a leading company in the genomics industry, specializing in DNA sequencing and array-based technologies for genetic analysis.

Illumina, Inc.

Thermo Fisher Scientific is a prominent company offering a wide range of biotechnology products and services, including genetic analysis and sequencing solutions.

Thermo Fisher Scientific

Pacific Biosciences is a key player in the genomics industry, known for its long-read sequencing technology and comprehensive genomic analysis solutions.

Pacific Biosciences

ProPhase Labs is a biotech, genomics, and diagnostics company that offers Whole Genome Sequencing, develops groundbreaking compounds and products, and licenses and commercializes products. The company also provides OTC manufacturing services and consumer healthcare product development.

ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster. The company also provides contract manufacturing services, such as product development, pre-commercialization, production, warehousing, and distribution; SARS-CoV-2 (COVID-19) and COVID-19 viral mutation polymerase chain reaction tests through saliva and nasal swab methods; and other respiratory pathogen panel molecular testing services, as well as personal genomics products and services. It serves national chain drug, internet-based, and various regional retailers. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York.

ProPhase Labs, Inc.

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general	May 6, 2024 7:41 AM	38555f04
public peers	general	May 6, 2024 7:41 AM	3316ca56
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	May 6, 2024 7:41 AM	1da99190
company summary	general
signals	general
crunchbase trigger	general	Nov 27, 2024 12:50 PM	be1cc831
crunchbase profile	general
li profile	general	May 6, 2024 7:41 AM	00fe272e
translate crunchbase fundingrounds	general
peers	general
news basic	general	May 6, 2024 7:41 AM	1ebaeb1a
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:PROPHASELABS

ProPhase Labs

Last Close

0.78

22/11 21:00

Market Cap

66.20M

Beta: -

Volume Today

199.40K

Avg: -